PERCUTANEOUS ENDOVENOUS INTERVENTION PLUS NEW ORAL ANTICOAGULANTS IN CANCER PATIENTS WITH LOWER EXTREMITY DEEP VENOUS THROMBOSIS

Deep venous thrombosis (DVT) portends a poor prognosis in patients with cancer. The treatment of choice has been low molecular weight heparins ( LMWH). Due to presence of resistance, warfarin is not the preferred anticoagulant . There is a paucity of data on the use of new oral anticoagulants (NOAC